https://www.aigom.it/wp-content/uploads/2026/04/ARTAPRILE.png458400Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-04-13 16:47:532026-05-05 09:05:28ROMIPLOSTIM VERSUS PLACEBO FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
https://www.aigom.it/wp-content/uploads/2026/04/Screenshot-2026-04-08-115157.png711442Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-04-08 09:48:552026-06-23 06:55:5415 GIUGNO 2026-AIGOM LE NOVITA’ DA CHICAGO 2026: L’EVOLUZIONE DELLE CONOSCENZE IN ONCOLOGIA
https://www.aigom.it/wp-content/uploads/2026/04/Screenshot-2026-04-08-112946.png1060748Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-04-08 09:43:472026-04-08 09:43:47AIGOM 2026: NOVITA’ NEL TRATTAMENTO DELLE NEOPLASIE GINECOLOGICHE, VERONA 21 APRILE 2026
https://www.aigom.it/wp-content/uploads/2026/03/ART17.3.png1114700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-17 08:26:422026-03-17 08:26:42ADDITION OF CARBOPLATIN TO SEQUENTIAL TAXANE-ANTHRACYCLINE NEOADJUVANT CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER: A PHASE III RANDOMIZED CONTROLLED TRIAL.
https://www.aigom.it/wp-content/uploads/2026/03/art10.3.png1079700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-10 08:22:402026-03-10 08:22:40TEN-YEAR SURVIVAL AFTER POSTMASTECTOMY CHEST-WALL IRRADIATION IN BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2026/03/ART3.3.png1126700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-03 09:12:222026-03-03 09:12:22ADDRESSING COMMON MEDICATIONS THAT INFLUENCE IMMUNOTHERAPY RESPONSE IN SOLID TUMORS.
https://www.aigom.it/wp-content/uploads/2026/03/Screenshot-2026-03-27-105153.png1056749Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-25 09:51:302026-06-30 15:01:5426-27-28 MARZO 2026-NEGRAR DI VALPOLICELLA (VR)-SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
https://www.aigom.it/wp-content/uploads/2026/02/ART24.2.png1059700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-24 07:47:032026-02-24 07:47:03PALBOCICLIB FOR HORMONE-RECEPTOR POSITIVE, HER2-POSITIVE ADVANCED BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2026/02/ART17.2.png1030700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-17 09:13:392026-02-17 09:13:39TRASTUZUMAB DERUXTECAN PLUS PERTUZUMAB FOR HER2-POSITIVE METASTATIC BREAST CANCER
